SAN DIEGO and NEWARK, Del., April 28, 2026 /PRNewswire/ -- Recently, ACROBiosystems was honored as a "Protein Supplier to Watch in Cancer Research in 2026" at the CiteAb Awards. CiteAb accelerates ...
DAEJEON, South Korea, June 20, 2024 (GLOBE NEWSWIRE) -- Syntekabio (KOSDAQ: 226330), an artificial intelligence (AI) based drug development company, announced the signing of a strategic Memorandum of ...
Recently, ACROBiosystems successfully held its Innovation Day at Superlab Suisse Zürich Schlieren in Zurich, Switzerland, a ...
Pharmaceutical Technology on MSN
ACROBiosystems upgrades HEK293 licence solution for R&D compliance
Customers have authorisation to use HEK293 functional cell lines for research, discovery, and assay development.
SAN DIEGO and NEWARK, N.J., April 28, 2026 /PRNewswire/ -- From April 17 to 22, 2026, ACROBiosystems—a company dedicated to being a cornerstone of the global biopharmaceutical and healthcare ...
- Leading Scientists from China, Japan and South Korea Convene to Drive Organoid Research and Commercialization Li Liang's team at the SUSTech School of Medicine established a biobank of ...
ACROBiosystems, through ACRO Certify and under its Aneuro brand, recently announced the launch of in vivo electrophysiology solutions for neuroscience research with Diagnostic Biochips. Together, the ...
This summary provides an overview of the most significant critical numbers from each of the Acrobiosystems financial reports, including the Acrobiosystems Co Ltd income statement, balance sheet, and ...
In this interview, Dr. Yinan Jiang discusses ACROBiosystems' efforts in the fight against COVID-19 and the search for a vaccine How has ACROBiosystems been involved in the fight against COVID-19?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results